.
Shaun is an experienced biotechnology executive with over 20 years of experience in drug development with Pfizer, GSK, Syntaxin, ImmBio, Biosceptre and Inflection Biosciences.
Shaun holds a D. Phil from the University of York and researched CNS biology and signalling at the University of Cambridge, UK.